Ascendis Pharma A (ASND) FCF Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) FCF Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 1,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,105.00 |
| Dec 31, 2025 | 260.00 |
| Sep 30, 2025 | 9,726.00 |
| Jun 30, 2025 | 16,471.00 |
| Mar 31, 2025 | 9,155.00 |
| Dec 31, 2024 | -1,407.00 |
| Sep 30, 2024 | 16,137.00 |
| Jun 30, 2024 | 15,281.00 |
| Mar 31, 2024 | 32,882.00 |
| Dec 31, 2023 | 58,380.00 |
| Sep 30, 2023 | 36,809.00 |
| Jun 30, 2023 | 163,671.00 |
| Mar 31, 2023 | 142,500.00 |
| Dec 31, 2022 | -40,288.00 |
| Sep 30, 2022 | 712,084.00 |
| Jun 30, 2022 | 896,274.00 |
| Mar 31, 2022 | 854,179.00 |
| Dec 31, 2021 | -1,297.00 |
| Sep 30, 2021 | -582,605.00 |
| Jun 30, 2021 | -729,857.00 |